Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer

PURPOSE: Patients with clinically node-positive breast cancer planned for neoadjuvant systemic therapy (NAST) may draw advantages from the nodal downstaging effect and reduce the extent of axillary surgery with sentinel lymph node biopsy (SLNB) performed after NAST. Since there are concerns about lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zetterlund, Linda Holmstrand, Frisell, Jan, Zouzos, Athanasios, Axelsson, Rimma, Hatschek, Thomas, de Boniface, Jana, Celebioglu, Fuat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387036/
https://www.ncbi.nlm.nih.gov/pubmed/28224384
http://dx.doi.org/10.1007/s10549-017-4164-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387036/
https://www.ncbi.nlm.nih.gov/pubmed/28224384
http://dx.doi.org/10.1007/s10549-017-4164-1

Ejemplares similares